Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.17152586 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p><strong>Ambulatory Arrhythmia Monitoring Devices Market Poised for Strong Growth, Projected to Reach USD 10.59 Billion by 2032</strong></p> <p>The global <a href="https://www.fortunebusinessinsights.com/ambulatory-arrhythmia-monitoring-devices-market-102507">ambulatory arrhythmia monitoring devices market</a> is on a significant upward trajectory, driven by an increasing prevalence of cardiovascular diseases, technological advancements, and a growing geriatric population. According to a report by Fortune Business Insights, the market size was valued at <strong>USD 6.21 billion in 2024</strong> and is projected to expand from <strong>USD 6.60 billion in 2025</strong> to <strong>USD 10.59 billion by 2032</strong>. This growth represents a compound annual growth rate (<strong>CAGR) of 7.0%</strong> during the forecast period of 2025-2032.</p> <p><strong>Key Market Drivers and Trends</strong></p> <p>The primary factor fueling the market's expansion is the rising incidence of cardiovascular disorders, particularly atrial fibrillation (AFib). The demand for continuous and effective monitoring solutions to detect and manage these conditions outside of a traditional hospital setting is higher than ever. Furthermore, the world's aging population, which is more susceptible to cardiac arrhythmias, is a significant contributor to the growing patient pool and subsequent demand for monitoring devices.</p> <p>Technological innovation is another critical driver. The development of smaller, more user-friendly devices with enhanced data transmission capabilities and artificial intelligence (AI) integration for improved diagnostic accuracy is revolutionizing the market. These advancements have led to a notable shift from traditional Holter monitors to more advanced options like mobile cardiac telemetry (MCT) and implantable loop recorders (ILRs). The COVID-19 pandemic also positively impacted the market by accelerating the adoption of remote patient monitoring technologies to minimize hospital visits.</p> <p>However, the market's growth is not without challenges. Stringent regulatory policies for device approval and instances of product recalls can act as restraining factors, potentially hindering market expansion.</p> <p><strong>Market Segmentation Insights</strong></p> <p>The ambulatory arrhythmia monitoring devices market can be analyzed through several key segments:</p> <ul> <li><strong>By Device:</strong> The market includes Holter monitors, event monitors, mobile cardiac telemetry (MCT), and implantable loop recorders (ILRs). In 2024, the Holter monitors segment held the largest market share, attributed to its widespread use and established reimbursement policies.</li> <li><strong>By Application:</strong> Key applications include monitoring for Tachycardia, Bradycardia, and Premature Contractions. The Tachycardia segment, especially Atrial Fibrillation, is a major focus due to its high prevalence.</li> <li><strong>By End-user:</strong> The primary end-users are Hospitals & Clinics, Diagnostic Centers, and Homecare Settings. Hospitals & Clinics dominated the market in 2024, owing to the high volume of diagnostic procedures performed in these facilities.</li> </ul> <p><strong>Regional Market Analysis</strong></p> <p>Geographically, the market is led by <strong>North America</strong>, which commanded a dominant market share of <strong>46.69% in 2024</strong>. This leadership is attributed to the region's high prevalence of cardiovascular diseases, advanced healthcare infrastructure, favorable reimbursement scenarios, and the strong presence of key industry players.</p> <ul> <li><strong>Europe</strong> stands as the second-largest market, driven by the increasing adoption of advanced monitoring technologies and supportive government policies.</li> <li>The <strong>Asia Pacific</strong> region is projected to witness the fastest growth rate during the forecast period. This is due to rising healthcare expenditure, growing awareness about early disease diagnosis, and a rapidly expanding patient population in countries like China and India.</li> </ul> <p><strong>Competitive Landscape</strong></p> <p>The market is characterized by the presence of several established companies that focus on innovation, strategic partnerships, and mergers and acquisitions to strengthen their market position. Some of the key players profiled in the market include:</p> <ul> <li>Medtronic</li> <li>Abbott</li> <li>GE HealthCare</li> <li>iRhythm Technologies, Inc.</li> <li>Baxter International Inc. (Hillrom)</li> <li>Koninklijke Philips N.V.</li> <li>Biotronik</li> <li>Asahi Kasei Corporation</li> </ul> <p>These companies are continuously investing in research and development to launch next-generation devices that offer improved patient comfort and superior diagnostic capabilities, thereby shaping the future of ambulatory cardiac monitoring.</p> <p>For more detailed information and data, please refer to the full report.</p> <p><strong>Source:</strong> <a href="https://www.fortunebusinessinsights.com/ambulatory-arrhythmia-monitoring-devices-market-102507">https://www.fortunebusinessinsights.com/ambulatory-arrhythmia-monitoring-devices-market-102507</a></p>